Glucagon-like peptide-1 (GLP-1) compounds have emerged as a compelling therapeutic target for managing metabolic disorders. These naturally occurring substances are secreted by the gut in response to nutrient intake, https://monobookmarks.com/story20367577/unveiling-the-therapeutic-potential-of-glp-1-peptides